(Q54526210)

30 May 2018

title

Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy. (English)

1 reference

30 May 2018

0 references

1 reference

5

Katherine J Kelly

1 reference

30 May 2018

author name string

Jesus Dominguez

1

1 reference

30 May 2018

Pengfei Wu

2

1 reference

30 May 2018

C Subah Packer

3

1 reference

30 May 2018

Constance Temm

4

1 reference

30 May 2018

publication date

27 June 2007

1 reference

30 May 2018

American Journal of Physiology - Renal Physiology

published in

1 reference

30 May 2018

volume

293

1 reference

30 May 2018

issue

3

1 reference

30 May 2018

page(s)

F670-9

1 reference

30 May 2018

Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Prevention of loss of renal function over time in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Macrophage migration inhibitory factor: a regulator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

The metabolic syndrome and chronic kidney disease in U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

A novel mouse model of lipotoxic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Lipids and diabetic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

The transforming growth factor-beta superfamily of receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Blocking IL-1 in systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Renal injury: similarities and differences in male and female rats with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Lymphocyte-Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide Depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Glycemic status and development of kidney disease: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

AMP-activated protein kinase and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

The AMP-activated protein kinase pathway--new players upstream and downstream.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Liver triglyceride secretion and lipid oxidative metabolism are rapidly altered by leptin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Progression of chronic kidney disease: can it be prevented or arrested?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Directing transition from innate to acquired immunity: defining a role for IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Adiponectin is a negative regulator of NK cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

AMP-activated protein kinase signaling in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Adiposity of the heart, revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

The course of diabetic glomerulopathy in patients with type I diabetes: a 6-year follow-up with serial biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Lipid droplets gain PAT family proteins by interaction with specialized plasma membrane domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Peroxisome proliferator-activated receptor-α regulates postischemic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Different domains cooperate to target the human ribosomal L7a protein to the nucleus and to the nucleoli

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

An endothelial receptor for oxidized low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Ceramides in insulin resistance and lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

Insulin Resistance and Microalbuminuria: A Cross-Sectional, Case-Control Study of 158 Patients With Type 2 Diabetes and Different Degrees of Urinary Albumin Excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00021.2007

10.1152/AJPRENAL.00021.2007

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

PubMed ID

17596532

1 reference

30 May 2018